Back to search

What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?

Data up to Jan 2025

Published2007
Citations290
References28

Total Citations Per Year

Abstract

References (28)

“Mini-mental state”

1975 • 82,784 citations

Clinical diagnosis of Alzheimer's disease

1984 • 27,279 citations

The Clinical Dementia Rating (CDR)

1993 • 8,861 citations

Frontotemporal lobar degeneration

1998 • 4,937 citations

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

1991 • 4,669 citations

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

1996 • 3,940 citations

Practice parameter: Management of dementia (an evidence-based review) [RETIRED]

2001 • 1,742 citations

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

1997 • 1,680 citations

Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.

1994 • 1,291 citations

Practice parameter: Diagnosis of dementia (an evidence-based review)

2001 • 1,285 citations

Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers

1992 • 1,181 citations

Prevalence and severity of cognitive impairment with and without dementia in an elderly population

1997 • 999 citations

Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease

1997 • 938 citations

Positron Emission Tomography in Evaluation of Dementia

2001 • 882 citations

Prediction of cognitive decline in normal elderly subjects with 2-[ 18 F]fluoro-2-deoxy- <scp>d</scp> -glucose/positron-emission tomography (FDG/PET)

2001 • 619 citations

Mild cognitive impairment

2003 • 552 citations

Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

2001 • 510 citations

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease

1997 • 422 citations

FDG PET imaging in patients with pathologically verified dementia.

2000 • 344 citations

SPECT perfusion imaging in the diagnosis of Alzheimer’s disease

2001 • 252 citations

Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease

1996 • 241 citations

Brain imaging evidence of preclinical Alzheimer's disease in normal aging

2006 • 214 citations

PET studies in dementia

2003 • 212 citations

Cerebral glucose metabolism in patients with frontotemporal dementia.

1998 • 208 citations

An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type

1994 • 164 citations

A comparison of classification methods for differentiating fronto‐temporal dementia from Alzheimer's disease using FDG‐PET imaging

2004 • 97 citations

Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET

2003 • 55 citations

Differential Regional Cerebral Uptake of &lt;sup&gt;18&lt;/sup&gt;F-Fluoro-2-Deoxy-&lt;i&gt;D&lt;/i&gt;-Glucose in Alzheimer’s Disease and Frontotemporal Dementia at Initial Diagnosis

2001 • 41 citations

Cited By (0)

Loading...